Krakow, Poland – 06 June 2017 – Selvita is a proud sponsor of the upcoming 18th Drug Discovery Summit which will take place on June 12 – 13, 2017, in Berlin, Germany.
This event will gather over 250 delegates representing leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions, and will feature 55 presentations, case studies and panel discussions focused on the key issues in drug discovery and medicinal chemistry.
The 18th Drug Discovery Summit is co-located with 5th Annual Discovery Chemistry and Drug Design Congress as well as an inaugural edition of Microbiome Discovery and Development Congress.
Come join us a for a Selvita presentation delivered by our
Head of Targeted Therapeutics Platform, dr. Tomasz Rzymski, who will talk about:
“Rationale for the further clinical development of CDK8 inhibitor SEL120-34A as a safe and personalized therapeutic approach in AML“.
The presentation will take place on Monday, June 12, 09:00 am (CET).
Throughout the whole event you can visit us at booth #20!
More about the event